Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  acivicin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 32 for your search:
Start Over
Phase I/II Chemotherapy with AT-125/CACP in Patients with non-Small Cell Carcinoma of the Lung (Summary Last Modified 02/88)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: CAN-NCIC-IND17, NCI-T84-0489W, T84-0489, IND17
Phase II Chemotherapy with Acivicin for Advanced Colorectal and Pancreatic Cancers
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DT-8135
Phase II Chemotherapy with Acivicin for Recurrent, Metastatic, or Nonresectable Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-8341
Phase II Pilot Evaluation of Acivicin for Dukes D or Recurrent, Inoperable Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: EST-PD-281, EST-P-D281
Phase II Master Protocol for Evaluation of New Agents for Previously Treated Metastatic Breast Cancer --- AT-125, A-TDA
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2182
Phase II Master Protocol for Evaluation of New Agents for Residual, Recurrent, or Metastatic Primary Liver Cancer --- Acivicin vs 4'-Deoxydoxorubicin
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2282
Phase II Master Protocol Chemotherapy for Previously Treated Stage III/IV Ovarian Adenocarcinoma --- VBL vs AT-125
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-5882
Phase II Master Protocol Chemotherapy for Inoperable, Metastatic Malignant Melanoma --- VBL; AT-125; CBDCA; FAMP; CCNU; Alpha-2-Interferon
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2683
Phase II Master Protocol for Advanced, Recurrent Pelvic Malignancies: AT-125
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-26P
Phase II Chemotherapy with AT-125 for Refractory Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: UMCT-1281
Phase II Chemotherapy with AT-125 for Advanced or Refractory non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: UMCT-1681A
Phase II Chemotherapy with Acivicin in Refractory or Extensive Small Cell and non-Small Cell Carcinoma of the Lung
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: SEG-LUN-82255
Phase II Master Protocol Chemotherapy for Refractory Adult ANLL, ALL, or CGL with Blast Crisis --- Phase I/II Evaluation of AT-125
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: BGSM-22183, WFU-22183, NCI-T83-1307W, T83-1307
Phase II Chemotherapy with AT-125 in Patients with Nonresectable Malignant Mesothelioma
Phase: Phase II
Type: Treatment
Status: Completed
Age: under 71
Sponsor: NCI
Protocol IDs: EST-PA-783, EST-P-A783
Phase II Chemotherapy with AT-125 vs FAMP in the Treatment of Recurrent Malignant Glioma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8400/05
Phase II Chemotherapy with Acivicin in Patients with Poor Prognosis non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND16, NCI-T84-0468W, T84-0468, IND16
Phase II Chemotherapy with Acivicin in Patients with Metastatic Renal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-213
Phase II Chemotherapy with Acivicin in Patients with Advanced Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-211
Phase II Chemotherapy with AT-125 for Patients with Nonresectable Colorectal Cancer Previously Untreated with Chemotherapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND23, NCI-T85-0178W, T85-0178, IND23
Phase II Chemotherapy with Acivicin in Patients with Advanced Bladder Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-212
Phase II Chemotherapy with Acivicin in Patients with Disseminated Germ Cell Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-214
Phase II Randomized Study of Chemotherapy with CDDP/VP-16 vs Acivicin in Patients with Metastatic non-Small Cell Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1585
Phase II Study of Acivicin in the Treatment of Patients with Recurrent or Persistent Glioma (Summary Last Modified 08/90)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: DUMC-198902, NCI-T90-0027D, T90-0027
Phase II Study of Acivicin in Patients with Advanced Pancreatic Carcinoma (Summary Last Modified 01/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WSU-C-95491, NCI-T91-0191D, T91-0191
Start Over